Skip to main content
Premium Trial:

Request an Annual Quote

Scripps Florida to Use GenoLogics Platform for Proteomics, Systems Bio Research

NEW YORK, Feb. 8 (GenomeWeb News) - Scripps Florida will use GenoLogics' lab- and data-management system in its proteomics and systems biology research, GenoLogics said today.


According to GeneLogics, Scripps Florida, a 2-year-old extension of the La Jolla, Calif.-based Scripps Research Institute, is focused on biomedical research, technology development, and drug design.


Its proteomics program focuses on developing and applying advanced technologies in mass spectrometry-based proteomics to answer questions on how proteins are modified by cells in certain diseases, GenoLogics said.


Nick Tsinoremas, senior director and head of informatics at Scripps Florida, said the center decided to work with GeneLogics because it wanted "a system that can cross over with other discipline areas, such as genotyping, microarray and gene expression."


Financial details were not discussed.

The Scan

Panel Recommends Pfizer-BioNTech Vaccine for Kids

CNN reports that the US Food and Drug Administration advisory panel has voted in favor of authorizing the Pfizer-BioNTech SARS-CoV-2 vaccine for children between 5 and 11 years old.

Sharing How to Make It

Merck had granted a royalty-free license for its COVID-19 treatment to the Medicines Patent Pool, according to the New York Times.

Bring it Back In

Bloomberg reports that a genetic analysis has tied a cluster of melioidosis cases in the US to a now-recalled aromatherapy spray.

Nucleic Acids Research Papers on SomaMutDB, VThunter, SCovid Databases

In Nucleic Acids Research this week: database of somatic mutations in normal tissue, viral receptor-related expression signatures, and more.